A number of recent case reports and series have identified a subgroup of atypical fractures of the femoral shaft associated with bisphosphonate use. A population-based study did not support this ...

Please provide your email address to receive an email when new articles are posted on . Subtrochanteric fractures of the femur can challenge even the experienced surgeon and preoperative assessment ...

Please provide your email address to receive an email when new articles are posted on . The FDA has ruled out a suggested link between bisphosphonate use and risk for atypical subtrochanteric femur ...

This interesting study shows that the incidence of more rare femoral fractures such as subtrochanteric fractures was stable from 1996 to 2006, although the overall incidence of hip fracture is ...

March 25, 2010 (UPDATED March 30, 2010) — Subtrochanteric and diaphyseal femur fractures are rare, even with bisphosphonate use for up to 10 years, according to the results of an analysis of 3 trials ...

This page lists all known medications that could potentially lead to 'Subtrochanteric Femur Fracture' as a side effect. It's important to note that mild side effects are quite common with medications.

Older women who used bisphosphonates (medications that prevent loss of bone mass) for five years or more were more likely to experience "atypical" fractures involving the femoral shaft or ...

The agency says it will work with outside experts to gather more information. March 10, 2010— -- The U.S. Food and Drug Administration announced today that it will look into whether a link exists ...

Since 2007, there have been several reports suggesting a potential association between the use of bisphosphonates and the occurrence of subtrochanteric or so-called atypical femoral fracture. 1–4 ...

(Corrects to show Actonel is owned by Warner Chilcott, 4th paragraph) * FDA says no thigh fracture risk with bisphosphonates * Bisphosphonates such as Fosamax treat osteoporosis * FDA statement ...

U.S. regulators said they have found no link between oral bisphosphonate osteoporosis medications such as Merck & Co Inc.'s Fosamax and certain thigh bone fractures. The U.S. Food and Drug ...